79 related articles for article (PubMed ID: 20233183)
1. Time-dependent inhibition (TDI) of CYP3A4 and CYP2C9 by noscapine potentially explains clinical noscapine-warfarin interaction.
Fang ZZ; Zhang YY; Ge GB; Huo H; Liang SC; Yang L
Br J Clin Pharmacol; 2010 Feb; 69(2):193-9. PubMed ID: 20233183
[TBL] [Abstract][Full Text] [Related]
2. Time-dependent inhibition of human drug metabolizing cytochromes P450 by tricyclic antidepressants.
Polasek TM; Miners JO
Br J Clin Pharmacol; 2008 Jan; 65(1):87-97. PubMed ID: 17662092
[TBL] [Abstract][Full Text] [Related]
3. Deep Learning Models Compared to Experimental Variability for the Prediction of CYP3A4 Time-Dependent Inhibition.
Fluetsch A; Trunzer M; Gerebtzoff G; Rodríguez-Pérez R
Chem Res Toxicol; 2024 Apr; 37(4):549-560. PubMed ID: 38501689
[TBL] [Abstract][Full Text] [Related]
4. Applicability of second-generation upcyte® human hepatocytes for use in CYP inhibition and induction studies.
Ramachandran SD; Vivarès A; Klieber S; Hewitt NJ; Muenst B; Heinz S; Walles H; Braspenning J
Pharmacol Res Perspect; 2015 Oct; 3(5):e00161. PubMed ID: 26516577
[TBL] [Abstract][Full Text] [Related]
5. The current status of time dependent CYP inhibition assay and in silico drug-drug interaction predictions.
Yan Z; Caldwell GW
Curr Top Med Chem; 2012; 12(11):1291-7. PubMed ID: 22571791
[TBL] [Abstract][Full Text] [Related]
6. NADPH-Independent Inactivation of CYP2B6 and NADPH-Dependent Inactivation of CYP3A4/5 by PBD: Potential Implication for Assessing Covalent Modulators for Time-Dependent Inhibition.
Kosaka M; Zhang D; Wong S; Yan Z
Drug Metab Dispos; 2020 Aug; 48(8):655-661. PubMed ID: 32482757
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of sanguinarine on human liver cytochrome P450 enzymes.
Qi XY; Liang SC; Ge GB; Liu Y; Dong PP; Zhang JW; Wang AX; Hou J; Zhu LL; Yang L; Tu CX
Food Chem Toxicol; 2013 Jun; 56():392-7. PubMed ID: 23500771
[TBL] [Abstract][Full Text] [Related]
8. Mechanism-based inhibition of CYP1A1 and CYP3A4 by the furanocoumarin chalepensin.
Ueng YF; Chen CC; Yamazaki H; Kiyotani K; Chang YP; Lo WS; Li DT; Tsai PL
Drug Metab Pharmacokinet; 2013; 28(3):229-38. PubMed ID: 23257392
[TBL] [Abstract][Full Text] [Related]
9. Clinically significant CYP2C inhibition by noscapine but not by glucosamine.
Rosenborg S; Stenberg M; Otto S; Ostervall J; Masquelier M; Yue QY; Bertilsson L; Eliasson E
Clin Pharmacol Ther; 2010 Sep; 88(3):343-6. PubMed ID: 20668444
[TBL] [Abstract][Full Text] [Related]
10. Involvement of multiple cytochrome P450 isoforms in naproxen O-demethylation.
Tracy TS; Marra C; Wrighton SA; Gonzalez FJ; Korzekwa KR
Eur J Clin Pharmacol; 1997; 52(4):293-8. PubMed ID: 9248768
[TBL] [Abstract][Full Text] [Related]
11. A Semi-Mechanistic Population Pharmacokinetic Model of Noscapine in Healthy Subjects Considering Hepatic First-Pass Extraction and CYP2C9 Genotypes.
Chen Z; Taubert M; Chen C; Boland J; Dong Q; Bilal M; Dokos C; Wachall B; Wargenau M; Scheidel B; Wiesen MHJ; Schaeffeler E; Tremmel R; Schwab M; Fuhr U
Drugs R D; 2024 May; ():. PubMed ID: 38809387
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Dry Heating, Water Rinsing, and Baking on Concentrations of the Opium Alkaloid Noscapine in Poppy Seeds.
Shetge SA; Redan BW
ACS Food Sci Technol; 2022 Feb; 2(3):541-547. PubMed ID: 35558138
[TBL] [Abstract][Full Text] [Related]
13. In vitro inhibitory effect of obtusofolin on the activity of CYP3A4, 2C9, and 2E1.
Liu N; Chen P; Du X; Sun J; Han S
BMC Complement Med Ther; 2021 Sep; 21(1):218. PubMed ID: 34470620
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory Effects of
Seo HJ; Ji SB; Kim SE; Lee GM; Park SY; Wu Z; Jang DS; Liu KH
Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33802239
[No Abstract] [Full Text] [Related]
15. Inhibition of drug-metabolizing enzymes by Qingfei Paidu decoction: Implication of herb-drug interactions in COVID-19 pharmacotherapy.
Zhang F; Huang J; Liu W; Wang CR; Liu YF; Tu DZ; Liang XM; Yang L; Zhang WD; Chen HZ; Ge GB
Food Chem Toxicol; 2021 Mar; 149():111998. PubMed ID: 33476691
[TBL] [Abstract][Full Text] [Related]
16.
Zhang N; Liu J; Chen Z; Dou W
Pharm Biol; 2019 Dec; 57(1):571-576. PubMed ID: 31456483
[No Abstract] [Full Text] [Related]
17. Interaction of OTC drug noscapine and acenocoumarol and phenprocoumon.
Lokhorst B; Rolfes L; Jessurun NT
Br J Clin Pharmacol; 2019 May; 85(5):1041-1043. PubMed ID: 30809820
[No Abstract] [Full Text] [Related]
18. Inhibitory effects of tanshinones towards the catalytic activity of UDP-glucuronosyltransferases (UGTs).
Zhang XX; Cao YF; Wang LX; Yuan XL; Fang ZZ
Pharm Biol; 2017 Dec; 55(1):1703-1709. PubMed ID: 28466663
[TBL] [Abstract][Full Text] [Related]
19. Metabolic mapping of A3 adenosine receptor agonist MRS5980.
Fang ZZ; Tosh DK; Tanaka N; Wang H; Krausz KW; O'Connor R; Jacobson KA; Gonzalez FJ
Biochem Pharmacol; 2015 Sep; 97(2):215-23. PubMed ID: 26212548
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
